There were 92 press releases posted in the last 24 hours and 170,882 in the last 365 days.

BridgeMed Solutions Offers Bovine & Porcine Tissue Patches in Market Led by Edward Lifesciences and Medtronic Inc.

Fixed Bovine Pericardium

Fixed Porcine Pericardium

Cross-Linked Bovine and Porcine Pericardium for Transcatheter Heart Valve Industry. Offers Custom Sizes, Thicknesses & Treatments. Low Cost and Quick Delivery.

We provide superior quality GBR1, defect free glut fixed custom manufactured Bovine and Porcine tissue patches per client’s request for the heart valve industry,”
— Tara Kupumbati, PhD., President and CEO of BridgeMed Solutions Inc.

IRVINE, CA, UNITED STATES, October 10, 2017 /EINPresswire.com/ -- Irvine, CA – Oct. 2, 2017 Tara Kupumbati, President at BridgeMed Solutions Inc., announced the company’s in-house manufacturing of custom bovine and porcine pericardium tissue patches to manufacture Transcatheter Aortic Valves (TAVR), Transcatheter Mitral Valves (TMVR), Tricuspid and Pulmonic Valves.

BridgeMed Solutions is a pioneer in the field of glut cross-linking tissue patches for transcatheter aortic, mitral, pulmonic, and tricuspid valves. The firm understands that each client is different and offers multiple sizes and thicknesses of patches to accommodate those requirements.

Extreme care is taken to ensure that patches are of the highest quality and free of particles, scratches or excessive wrinkles. Tissue patches are shipped sterilized & can be shipped in as little as three days. The company can accommodate batches of all sizes and thickness.

BridgeMed Solutions has extensive experience in custom porcine & bovine pericardium manufacturing and all of the patches are produced in their own facility in Irvine, CA. The company supplies the tissue patches to startups to global medical device companies.

Apart from tissue patches, BridgeMed Solutions also provides end-to-end services contract manufacturing for TAVR, TMVR, Tricuspid and Pulmonic Valves. As part of the consulting services, the company provides disease monitoring, tissue traceability, viral inactivation, biocompatibility studies, and anti-calcification treatment services to startup to global medical device companies.

PhD scientists, tissue engineers, stent experts, and delivery system specialists are all integral elements of the company’s team. BridgeMed Solutions takes pride in helping companies take advantage by using their tissue patches, contract manufacturing and consulting services to save time and cost.


About BridgeMed Solutions

BridgeMed Solutions is the leading contract manufacturing organization (CMO) in the transcatheter heart valve area. The company produces custom transcatheter aortic valve (TAVR), transcatheter mitral valve (TMVR), and transcatheter tricuspid valves from scratch per client requirements. The company provides highly-qualified in-house consultants to address areas that include biocompatibility, sterilization, viral inactivation qualification, QMS, regulatory submissions and FIH studies. For more information, visit us at www.bridgemedsolutions.com

NYSE: EW, STJ, LIVN, BSX, ICUI, MDT, CRY, ABT, ABMD, DXTR, THOR, SPNC, MMSI, HNSN, OCPNY, CNMD, ANGO, TFX, SYK, JNJ, IART, BAX, LMAT, CRY, BCR, VASC, AVGR, TRIV, CSII, BDX, SPNC, SKLN, SNN, PFE

Tara Kupumbati
BridgeMed Solutions Inc.
949-315-7157
email us here